Association of Alendronate and Risk of Cardiovascular Events in Patients With Hip Fracture

Journal of Bone and Mineral Research - United States
doi 10.1002/jbmr.3448
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Association Between Alendronate and All-Cause Mortality and Cardiovascular Mortality Among Hip Fracture: An Alternative Explanation

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2018English

Association of Receiving Multiple, Concurrent Fracture-Associated Drugs With Hip Fracture Risk

JAMA network open
Medicine
2019English

Body Mass Index and Risk of Adverse Cardiac Events in Elderly Patients With Hip Fracture: A Population-Based Study

Journal of the American Geriatrics Society
GerontologyGeriatrics
2009English

Pressure Ulcer Risk in Hip Fracture Patients

Acta Orthopaedica Scandinavica
2004English

Association of Gait Speed and Grip Strength With Risk of Cardiovascular Events in Patients on Haemodialysis: A Prospective Study

BMC Nephrology
Nephrology
2019English

External Hip Protectors and Risk of Hip Fracture

JAMA - Journal of the American Medical Association
Medicine
2003English

Risk of Major Cardiovascular Events in Patients With Type 2 Diabetes With and Without Prior Cardiovascular Events: Results From the Leader Trial

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Pioglitazone May Reduce Cardiovascular Events in High Risk Patients With Prediabetes

British Medical Journal
Medicine
2016English

Depression and Risk of Adverse Cardiovascular Events in Patients With Stable Coronary Artery Disease

The Bangkok Medical Journal
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy